Pharmafile Logo
Pharmafocus logo
Advanced Search
Obama image

Pharma to profit from Obama reforms

March 18, 2015
Sales and Marketing FDA, GlobalData, Obama, US, healthcare, insurance

President Obama’s healthcare reforms will drive massive growth in the US pharma market a new report is predicting. The size …

News
Valeant image

Valeant sprints ahead of Endo to secure Salix

March 18, 2015
Sales and Marketing Actavis, Canada, Endo, Valeant, Xifaxan, methylnaltrexone, rifaximin, salix

Salix Pharmaceuticals has accepted an improved $11.1 billion takeover swoop from Valeant Pharmaceuticals to beat rival bidder Endo International. The …

News
astrazeneca image

AstraZeneca buoyed by late-stage trial success

March 18, 2015
Sales and Marketing AstraZeneca, copd. asthma, formoterol fumarate, glycopyrronium, ptoo3, respiratory

AstraZeneca’s investigational respiratory drug has posted positive results in a Phase III trial in people with COPD, having found it …

News
Survey

The 2015 European Life Sciences Industry Survey on Customer Data

March 18, 2015

Dear Colleague, You are invited to take part in the 2015 European Life Sciences Industry Survey on Customer Data. Your …

Feature
GSK image

GSK premature babies drug starts late-stage trials

March 18, 2015
Sales and Marketing GSK, Retosiban, atosiban, babies, birth, oxytocin, premature

GlaxoSmithKline has initiated Phase III studies to evaluate the safety and efficacy of an investigational treatment for babies born prematurely. …

News
sharon_johnson_catalent

Catalent Pharma Solutions names new unit head

March 18, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing catalent pharma solutions, sharon johnson

UK pharma and healthcare products firm Catalent Pharma Solutions has picked its senior VP Sharon Johnson of the company’s quality …

Appointment

Baxter’s haemophilia drug performs

March 17, 2015
Sales and Marketing BAX 817, VIIa, baxter, haemophilia, rFVIIa

Baxter International has reported positive Phase III clinical trial results for its investigational haemophilia drug BAX 817. The recombinant factor VIIa …

News
Brilinta image

Mixed results for AstraZeneca in high-profile Brilinta study

March 17, 2015
Sales and Marketing American College of Cardiology, AstraZeneca, Brilinta, EMA, FDA, ticagrelor

Experts say AstraZeneca is at risk of ‘diminishing returns’ in the clinical advantages of its blood-thinning drug Brilinta, after it …

News
Jakavi image

Novartis blood cancer drug given EU nod

March 17, 2015
Sales and Marketing Cancer, EU, Jakavi, Novartis, oncology, polycythemia vera, ruxolitinib

Novartis’ blood cancer drug Jakavi has been given the green light in Europe to treat adult patients with polycythemia vera …

News
Sanofi Pasteur image

Sanofi affiliate to supply 37 million vaccines

March 17, 2015
Manufacturing and Production, Sales and Marketing GAVI, Sanofi, Sanofi Pasteur, Shantha Biotechnics, shan5, vaccines

Sanofi’s vaccines division Sanofi Pasteur has confirmed its affiliate Shantha Biotechnics in India has delivered the first 400,000 doses of …

News
Biogen image

Big pharma partners with government over $100m dementia fund

March 17, 2015
Research and Development, Sales and Marketing Alzheimer's, Biogen IDEC, GSK, J&J, JJ, Pfizer, government, jp morgan, lilly

Lilly, Pfizer, GSK, J&J and Biogen Idec are set to join a $100m Dementia Discovery Fund to boost research into …

News
richard_scheller

23andMe assigns chief scientific officer to new unit

March 17, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andm3, Richard Scheller

US personal genetics firm 23andMe has created a new therapeutics group and appointed pharma veteran Richard Scheller as chief science …

Appointment
23andme image

23andMe to move into drug development

March 16, 2015
Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, Pfizer, google

The Google-backed DNA test company 23andMe has announced plans to start using genetic data to design new drugs. In recent …

News
NHS image

NHS is struggling to improve cancer care

March 16, 2015
Sales and Marketing CRUK, Cancer, Department of Health, NHS, NHS England, oncology

The Department of Health and NHS England are struggling with the demand required to improve its cancer services according to …

News
Sanofi image

Sanofi and Amgen cholesterol drugs shine

March 16, 2015
Sales and Marketing Amgen, PCSK9, Repatha, Sanofi, alirocumab, evolocumab, praluent

Two large Phase III studies of Sanofi’s Praluent and Amgen’s Repatha have found the biologic cholesterol-lowering drugs are more effective …

News
Ofev image

Boehringer eyes Ofev success in IPF and beyond

March 16, 2015
Sales and Marketing Boehringer, Esbriet, Roche, ingelheim, inpulsis, ipd, ofev

Experts say the launch of Boehringer Ingelheim’s new treatment for idiopathic pulmonary fibrosis (IPF) offers stiff competition to Roche’s Esbriet …

News
Science image

Drug development contracts: can lessons be learned from healthcare delivery?

March 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, CRO, Les Rose, NHS, drug development, trials

There is a very good question to ask at the beginning of every project: “What does success look like?” If …

Feature
thomas_beck

Recipharm appoints quality management VP

March 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm, thomas beck

Contract development and manufacturing organisation Recipharm has appointed Thomas Beck to the new senior role of vice president of quality …

Appointment
ABPI image

Pharma pays £310 million underwriting UK meds bill

March 13, 2015
Sales and Marketing ABPI, NHS, PPRS, body, department, health pricing, pharma

Pharma has made a fourth quarter payment of £81 million to underwrite the 2014 UK medicines bill under the Pharmaceutical …

News
BMS image

BMS resubmits hepatitis C drug

March 13, 2015
Sales and Marketing BMS, NDA, daclatasvir gilead, hepatitis C, sovaldi

Bristol-Myers Squibb has resubmitted its hepatitis C (HCV) treatment for FDA approval despite previously backing out, as it spots a …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026